郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Pentamidine-induced long QT syndrome and block of hERG trafficking.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2005作者:Yuri A Kuryshev; Eckhard Ficker; Lu Wang; Peter Hawryluk; Adrienne T Dennis; Barbara A Wible; Arthur M Brown; Jiesheng Kang; Xiao-Liang Chen; Kaoru Sawamura; William Reynolds; David Rampe

药效评价Antiandrogenic effects in short-term in vivo studies of the fungicide fenarimol.

期刊:Toxicology发表年份:2005作者:Anne Marie Vinggaard; Helene Jacobsen; Stine Broeng Metzdorff; Helle Raun Andersen; Christine Nellemann

药效评价NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin.

期刊:Neuropharmacology发表年份:2005作者:Sudar Alagarsamy; Julie Saugstad; Lee Warren; Isabelle M Mansuy; Robert W Gereau; P Jeffrey Conn

药效评价Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2005作者:Richard H P Porter; Georg Jaeschke; Will Spooren; Theresa M Ballard; Bernd Büttelmann; Sabine Kolczewski; Jens-Uwe Peters; Eric Prinssen; Jürgen Wichmann; Eric Vieira; Andreas Mühlemann; Silvia Gatti; Vincent Mutel; Pari Malherbe